本页面由Tiger Trade Technology Pte. Ltd.提供服务

Drugs Made In America Acquisition Corp

10.86
0.0000
盘后:10.890.0300+0.28%16:00 EDT
成交量:35
成交额:382
市值:2.64亿
市盈率:58.80
高:10.86
开:10.86
低:10.86
收:10.86
52周最高:10.89
52周最低:10.28
股本:2,427.69万
流通股本:1,978.81万
量比:0.00
换手率:0.00%
股息:- -
股息率:- -
每股收益(TTM):0.1847
每股收益(LYR):0.1878
净资产收益率:--
总资产收益率:-1.46%
市净率:1.17
市盈率(LYR):57.84

数据加载中...

2026/09/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/09/15

重要事件披露

Form 8-K - Current report
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/20

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/07/20

重要事件披露

Form 8-K - Current report
2026/06/26

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/04/08

重要事件披露

Form 8-K - Current report
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/06

重要事件披露

Form 8-K - Current report